You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pde

Showing 1 - 25 of 593
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Seborrheic Dermatitis, Papulopustular Rosacea Trial in New York (PF-07038124, Placebo Ointment)

Recruiting
  • Seborrheic Dermatitis
  • Papulopustular Rosacea
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Aug 22, 2023

Behçet's Disease Trial in Beijing (Hemay005, Placebo)

Recruiting
  • Behçet's Disease
  • Beijing, Beijing, China
    Peking University People's Hospital
Nov 17, 2023

Retinitis Pigmentosa Trial in Tuebingen (subretinal injection of rAAV.hPDE6A)

Active, not recruiting
  • Retinitis Pigmentosa
  • subretinal injection of rAAV.hPDE6A
  • Tuebingen, Germany
    Universitätsklinikum Tübingen, Department für Augenheilkunde
Dec 7, 2022

Erectile Dysfunction Trial in Saint Petersburg (PDE5 inhibitor (tadalafil) and BTL-6000 fSWT, PDE5 inhibitor (tadalafil))

Recruiting
  • Erectile Dysfunction
  • PDE5 inhibitor (tadalafil) and BTL-6000 fSWT
  • PDE5 inhibitor (tadalafil)
  • Saint Petersburg, Russian Federation
    SBPSU
Apr 10, 2023

Depression Trial run by the National Institute of Mental Health (NIMH) (18F-PF-06445974)

Recruiting
  • Depression
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 3, 2023

PDE6A-related Retinitis Pigmentosa in Preparation toGene Therapy

Enrolling by invitation
  • Retinitis Pigmentosa
    • Tübingen, Baden-Württemberg, Germany
      Institute for Ophthalmic Research, University Tübingen, Germany
    Oct 25, 2022

    Pyridoxine Dependant Epilepsy Trial in Nijmegen, London (PDE MAX)

    Recruiting
    • Pyridoxine Dependant Epilepsy
    • PDE MAX
    • Nijmegen, Netherlands
    • +1 more
    Dec 7, 2021

    Retinitis Pigmentosa Trial in Pittsburgh, Paris (SPVN06)

    Not yet recruiting
    • Retinitis Pigmentosa
    • Pittsburgh, Pennsylvania
    • +1 more
    Feb 17, 2023

    Healthy, Obese Trial in Nashville (Tadalafil, Placebo)

    Completed
    Has Results
    • Healthy
    • Obese
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    May 3, 2022

    Cystic Fibrosis Trial in Denver, Augusta (Sildenafil 40mg oral capsule, Placebo Oral capsule)

    Recruiting
    • Cystic Fibrosis
    • Sildenafil 40mg oral capsule
    • Placebo Oral capsule
    • Denver, Colorado
    • +1 more
    Aug 29, 2022

    Retinitis Pigmentosa Trial in Nantes (AAV2/5-hPDE6B)

    Active, not recruiting
    • Retinitis Pigmentosa
    • AAV2/5-hPDE6B
    • Nantes, France
      Clinique Ophtalmologique, CHU de Nantes
    Feb 28, 2022

    Obesity Trial in Nashville (Tadalafil 20 MG, Placebo)

    Recruiting
    • Obesity
    • Tadalafil 20 MG
    • Placebo
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Mar 29, 2022

    Heart Failure With Preserved Ejection Fraction Trial (IMR-687, IMR-687 Placebo)

    Withdrawn
    • Heart Failure With Preserved Ejection Fraction
    • (no location specified)
    May 23, 2022

    Retinitis Pigmentosa Trial in Pittsburgh, Paris (Ophthalmic examinations, Mobility Test)

    Active, not recruiting
    • Retinitis Pigmentosa
    • Ophthalmic examinations
    • Mobility Test
    • Pittsburgh, Pennsylvania
    • +1 more
    Apr 19, 2022

    Metastatic Colorectal Cancer, Cetuximab, Skin Toxicity Trial in Guangzhou (Crisaborole Ointment, Cetuximab)

    Recruiting
    • Metastatic Colorectal Cancer
    • +2 more
    • Guangzhou, Guangdong, China
      WeiWei Xiao
    Nov 3, 2023

    ive Alzheimer's Medicines - PDE5 Inhibitors vs Endothelin

    Active, not recruiting
    • Pulmonary Arterial Hypertension
    • PDE5 inhibitor
    • Endothelin Receptor Antagonists
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Nov 15, 2021

    Erectile Dysfunction Trial in Surabaya (Li-ESWT, Tadalafil 2.5Mg Tab)

    Completed
    • Erectile Dysfunction
    • Li-ESWT
    • Tadalafil 2.5Mg Tab
    • Surabaya, Jawa Timur, Indonesia
      dr. Soetomo General Hospital
    Sep 9, 2021

    Brain Tumor Trial in Stanford (Panitumumab-IRDye800, Pinpoint-IR9000 endoscopic/handheld device, Explorer Air camera)

    Not yet recruiting
    • Brain Tumor
    • Stanford, California
      Stanford Cancer Center
    Nov 9, 2022

    Cerebrovascular Disorders, Memory, Functional Recovery Trial in Maastricht (Roflumilast Oral Tablet)

    Recruiting
    • Cerebrovascular Disorders
    • +3 more
    • Roflumilast Oral Tablet
    • Maastricht, Limburg, Netherlands
      Maastricht University
    Oct 25, 2021

    Healthy Participants Trial (BMS-986278, Sildenafil, Placebo)

    Not yet recruiting
    • Healthy Participants
    • (no location specified)
    Jan 12, 2023

    Erectile Dysfunction Following Radiation Therapy, Phosphodiesterase Inhibitor Adverse Reaction, Platelet- Rich Plasma (PRP)

    Active, not recruiting
    • Erectile Dysfunction Following Radiation Therapy
    • +2 more
    • P shot arm ( Autologous Platelet Rich Plasma)
    • PDE5i arm
    • Mansoura, Outside U.S./Canada, Egypt
      Mansoura urology and nephrology center
    Mar 15, 2023

    Retrospective Natural History Study of Retinitis Pigmentosa

    Active, not recruiting
    • Retinitis Pigmentosa (RP)
      • Paris, France
        CHNO XV-XX Paris - CIC 1423
      Aug 3, 2021

      Invasive Breast Cancer Trial in Cleveland (Smart Goggle, Cardio-Green, SPY Elite Imaging system)

      Suspended
      • Invasive Breast Cancer
      • Smart Goggle
      • +6 more
      • Cleveland, Ohio
        Cleveland Clinic, Case Comprehensive Cancer Center
      Jan 5, 2023

      Underlying Conditions in Men Prescribed a PDE5 Inhibitor

      Completed
      Has Results
      • Erectile Dysfunction
      • +2 more
      • no intervention
      • (no location specified)
      Jul 15, 2021

      Schizophrenia Trial in Hungary, Poland (CPL500036 - low dose, CPL500036 - high dose, Placebo)

      Recruiting
      • Schizophrenia
      • CPL500036 - low dose
      • +2 more
      • Budapest, Hungary
      • +7 more
      May 4, 2022